C12N 2740/00043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2740/00043 (Viral genome or elements thereof as genetic vector) appears on 3 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 16
- Assignees
- 13
- Inventors
- 47
- Latest grant
- 14 Jul 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 2 |
| 2017 | 1 | 1 |
| 2018 | 0 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 0 |
| 2025 | 0 | 4 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Apparatus and methods for controlling cellular development14 Jul 2020US 10,711,242 B2The Board of Trustees of the Leland Stanford Junior University
- Vectors and methods to treat ischemia30 May 2017US 9,663,564 B2The Regents of the University of California
- Therapeutic use of the encoding sequence of the carboxy-terminal domain of the heavy chain of the tetanus toxin3 Feb 2015US 8,945,586 B2The Autonomous University of Barcelona
- Pseudovirus based neutralization assay for evaluating vaccine immunogenicity29 Jan 2026US 2026/0028644 A1Novavax, Inc.
- Modified plant virus system for delivery of nucleic acids into mammalian cells30 Oct 2025US 2025/0332284 A1
- T cell receptors targeting ewsr1-wt1 fusion protein and uses thereof21 Aug 2025US 2025/0262244 A1Memorial Hospital for Cancer and Allied Diseases
- Identifying disease-causing human ddx41 genetic variants10 Jul 2025US 2025/0223630 A1Wisconsin Alumni Research Foundation
- Chimeric Antigen Receptor-T Cells Targeting HIV-Infected Cells20 Feb 2025US 2025/0057884 A1Beijing Solobio Genetechnology Company Ltd.
Most cited
By later US patents